$25 Million Accredited Home Infusion and Closed-Door Specialty Pharmacy Licensed in 34 States with Multiple Locations
34-State Home Infusion Pharmacy with $4M EBITDA
On NextCompany since August 28, 2026 (today)
Location undisclosed
Business overview
An accredited home infusion pharmacy serves clients across 34 states. It holds ACHC accreditation and pursues URAC 3.0. The business has operated for over 40 years. Drug therapies include IVIG and rare-disease medications. 2018 projected revenue reached $25 million. Adjusted EBITDA approximated $4 million.
Who is a good fit for this business
- Buyers acquiring pharmacies licensed in 34 states.
- Acquirers seeking IVIG and limited-distribution drug access.
- Operators comfortable with USP compounding capabilities.
Details
Frequently Asked Questions
The pharmacy holds licenses in 34 states. It maintains multiple locations. ACHC accreditation supports operations.
Drug therapies include IVIG and specialty rare-disease medications. The business recently gained access to a limited-distribution medication. It compounds under USP guidelines.
2018 projected revenue reached $25 million. Adjusted EBITDA approximated $4 million. The business has operated for over 40 years.
The asking price stands at $25,000,000 plus inventory. The business pursues URAC 3.0 accreditation.